Total Payments
$726,622
2024 Payments
$139,676
Companies
44
Transactions
1,159
Medicare Patients
6,206
Medicare Billing
$356,754
Payment Breakdown by Category
Other$415,056 (57.1%)
Consulting$211,231 (29.1%)
Travel$53,612 (7.4%)
Food & Beverage$26,144 (3.6%)
Gifts$12,957 (1.8%)
Research$7,505 (1.0%)
Education$117.83 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $264,253 | 156 | 36.4% |
| Consulting Fee | $211,231 | 206 | 29.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $78,713 | 39 | 10.8% |
| Travel and Lodging | $53,612 | 186 | 7.4% |
| Grant | $35,000 | 1 | 4.8% |
| Food and Beverage | $26,144 | 537 | 3.6% |
| Honoraria | $24,165 | 20 | 3.3% |
| Gift | $12,957 | 2 | 1.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $12,925 | 6 | 1.8% |
| Unspecified | $7,505 | 4 | 1.0% |
| Education | $117.83 | 2 | 0.0% |
Payments by Type
General
$719,117
1,155 transactions
Research
$7,505
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $126,298 | 200 | $0 (2022) |
| ABBVIE INC. | $93,377 | 114 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $87,680 | 110 | $0 (2024) |
| Reichert, Inc. | $66,229 | 59 | $0 (2024) |
| Glaukos Corporation | $64,818 | 73 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $57,461 | 93 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $30,953 | 58 | $0 (2024) |
| Dompe US, Inc. | $27,694 | 31 | $0 (2024) |
| Sight Sciences, Inc. | $23,086 | 57 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $23,061 | 45 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139,676 | 205 | Bausch & Lomb Americas Inc. ($54,971) |
| 2023 | $100,806 | 139 | AbbVie Inc. ($43,108) |
| 2022 | $122,198 | 183 | ABBVIE INC. ($40,493) |
| 2021 | $83,734 | 164 | Allergan, Inc. ($39,774) |
| 2020 | $101,915 | 99 | Aerie Pharmaceuticals, Inc. ($25,281) |
| 2019 | $57,088 | 137 | Allergan Inc. ($17,931) |
| 2018 | $107,214 | 166 | Glaukos Corporation ($42,882) |
| 2017 | $13,990 | 66 | Allergan Inc. ($9,088) |
All Payment Transactions
1,159 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Ophthalmology | ||||||
| 12/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 12/13/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $47.80 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $581.95 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $72.72 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $12.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $44.19 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $194.96 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $120.65 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $120.16 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $26.79 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $26.15 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $14.99 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $12.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Glaukos Corporation | Radius (Device) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Glaucoma | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Glaukos Corporation | Photrexa (Drug) | Food and Beverage | Cash or cash equivalent | $61.62 | General |
| Category: Corneal Health | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH | NOVARTIS PHARMACEUTICALS CORPORATION | $7,275 | 1 |
| Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants to Timolol Maleate Ophthalmic Solution, USP, 0.5% | Glaukos Corporation | $121.52 | 2 |
| Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ABBVIE INC. | $108.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,569 | 1,954 | $314,549 | $94,955 |
| 2022 | 15 | 1,605 | 1,961 | $269,569 | $88,592 |
| 2021 | 19 | 1,521 | 1,859 | $267,088 | $87,170 |
| 2020 | 17 | 1,511 | 1,865 | $253,617 | $86,036 |
Total Patients
6,206
Total Services
7,639
Medicare Billing
$356,754
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 243 | 243 | $82,863 | $26,411 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 328 | $49,200 | $19,632 | 39.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 248 | 360 | $67,320 | $16,090 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 153 | $33,966 | $13,564 | 39.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 237 | 306 | $28,458 | $7,278 | 25.6% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 17 | 17 | $9,182 | $2,528 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 40 | 52 | $5,460 | $2,009 | 36.8% |
| 92145 | Measurement of corneal pressure | Office | 2023 | 200 | 208 | $11,024 | $1,660 | 15.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,032 | $1,353 | 33.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 52 | 54 | $4,374 | $1,084 | 24.8% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 22 | 48 | $3,777 | $986.92 | 26.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 106 | 106 | $6,148 | $785.19 | 12.8% |
| 92134 | Imaging of retina | Office | 2023 | 26 | 27 | $2,511 | $696.43 | 27.7% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 20 | 20 | $5,100 | $570.95 | 11.2% |
| 92025 | Ct scan of cornea | Office | 2023 | 13 | 14 | $1,134 | $307.22 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 236 | 236 | $74,092 | $24,284 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 332 | $45,992 | $20,743 | 45.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 235 | 324 | $55,926 | $14,739 | 26.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 234 | 297 | $25,551 | $7,254 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 71 | $14,537 | $6,314 | 43.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 108 | 150 | $14,262 | $5,504 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $6,170 | $2,311 | 37.5% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 39 | 78 | $5,596 | $1,739 | 31.1% |
| 92145 | Measurement of corneal pressure | Office | 2022 | 163 | 177 | $8,643 | $1,411 | 16.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 58 | 58 | $4,320 | $1,155 | 26.7% |
About Dr. Justin Schweitzer, O.D
Dr. Justin Schweitzer, O.D is a Optometrist healthcare provider based in Sioux Falls, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023047867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Schweitzer, O.D has received a total of $726,622 in payments from pharmaceutical and medical device companies, with $139,676 received in 2024. These payments were reported across 1,159 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($264,253).
As a Medicare-enrolled provider, Schweitzer has provided services to 6,206 Medicare beneficiaries, totaling 7,639 services with total Medicare billing of $356,754. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Sioux Falls, SD
- Active Since 07/02/2006
- Last Updated 05/21/2024
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1023047867
Products in Payments
- DURYSTA (Drug) $81,062
- VUITY (Drug) $55,182
- LUMIGAN (Drug) $52,835
- VYZULTA (Drug) $47,021
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $41,290
- MIEBO (Drug) $40,373
- Cequa (Drug) $26,665
- OXERVATE (Drug) $26,172
- Rhopressa (Drug) $23,517
- rocklatan (Drug) $20,092
- RETeval (Device) $17,250
- XDEMVY (Drug) $15,893
- rhopressa (Drug) $15,687
- EYEKINETIX (Device) $12,950
- XIIDRA (Drug) $12,841
- AcrySof (Device) $11,051
- LOTEMAX SM (Drug) $9,864
- iStent Trabecular Micro-Bypass Stent System (Device) $8,574
- OMNI (Device) $7,466
- OMNI(R) SURGICAL SYSTEM (US) (Device) $6,800
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Sioux Falls
Mitchel Ibach, O.d, O.D
Optometrist — Payments: $279,223
Optometrist $279,223
Jason Schmit, O.d, O.D
Optometrist — Payments: $97,145
Optometrist $97,145
Mr. Jeffery Sayler, Od, OD
Optometrist — Payments: $9,552
Optometrist $9,552
Travis Lehr, Od, OD
Optometrist — Payments: $7,237
Optometrist $7,237
Dr. Ryan Haiar, O.d, O.D
Optometrist — Payments: $6,861
Optometrist $6,861
Dr. Matthew Clarke, O.d, O.D
Optometrist — Payments: $4,973
Optometrist $4,973